112 related articles for article (PubMed ID: 2894250)
1. Proliferation, senescence, and neoplastic progression of beta cells in hyperplasic pancreatic islets.
Teitelman G; Alpert S; Hanahan D
Cell; 1988 Jan; 52(1):97-105. PubMed ID: 2894250
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia.
Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ
Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase in mouse pancreatic islet cells, in situ and after syngeneic transplantation to kidney.
Persson-Sjögren S; Forsgren S; Täljedal IB
Histol Histopathol; 2002 Jan; 17(1):113-21. PubMed ID: 11813861
[TBL] [Abstract][Full Text] [Related]
5. Cell lineage analysis of pancreatic islet development: glucagon and insulin cells arise from catecholaminergic precursors present in the pancreatic duct.
Teitelman G; Lee JK
Dev Biol; 1987 Jun; 121(2):454-66. PubMed ID: 2884153
[TBL] [Abstract][Full Text] [Related]
6. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Memoli VA; Longnecker DS
Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
[TBL] [Abstract][Full Text] [Related]
7. In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.
Hino S; Yamaoka T; Yamashita Y; Yamada T; Hata J; Itakura M
Diabetologia; 2004 Oct; 47(10):1819-30. PubMed ID: 15480536
[TBL] [Abstract][Full Text] [Related]
8. Neoplasia and hyperplasia of pancreatic endocrine tissue in the rat: an immunocytochemical study.
Spencer AJ; Andreu M; Greaves P
Vet Pathol; 1986 Jan; 23(1):11-5. PubMed ID: 3004001
[TBL] [Abstract][Full Text] [Related]
9. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.
Duvillié B; Currie C; Chrones T; Bucchini D; Jami J; Joshi RL; Hill DJ
Endocrinology; 2002 Apr; 143(4):1530-7. PubMed ID: 11897712
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of pancreatic beta-cell growth and regeneration: studies on rat insulinoma cells.
Nielsen JH
Exp Clin Endocrinol; 1989 May; 93(2-3):277-85. PubMed ID: 2550270
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
13. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.
Schuppin GT; Pons S; Hügl S; Aiello LP; King GL; White M; Rhodes CJ
Diabetes; 1998 Jul; 47(7):1074-85. PubMed ID: 9648831
[TBL] [Abstract][Full Text] [Related]
14. Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans.
Ballian N; Hu M; Liu SH; Brunicardi FC
Pancreas; 2007 Oct; 35(3):199-206. PubMed ID: 17895838
[TBL] [Abstract][Full Text] [Related]
15. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.
Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3576-80. PubMed ID: 7724601
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth.
Power RF; Holm R; Bishop AE; Varndell IM; Alpert S; Hanahan D; Polak JM
Gut; 1987; 28 Suppl(Suppl):121-9. PubMed ID: 2826309
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of the early genetic events in multistage carcinogenesis of malignant insulinoma.
Katić M; Hadzija M; Wrischer M; Pavelić K
Carcinogenesis; 1999 Aug; 20(8):1521-7. PubMed ID: 10426801
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis.
Vincent M; Guz Y; Rozenberg M; Webb G; Furuta M; Steiner D; Teitelman G
Endocrinology; 2003 Sep; 144(9):4061-9. PubMed ID: 12933680
[TBL] [Abstract][Full Text] [Related]
20. Increased cytokine-induced cytotoxicity of pancreatic islet cells from transgenic mice expressing the Src-like tyrosine kinase GTK.
Annerén C; Welsh M
Mol Med; 2001 May; 7(5):301-10. PubMed ID: 11474576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
